BiotechTube
Intelliseq

Intelliseq

Warsaw, Poland· Est.
intelliseq.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2016 and headquartered in Warsaw, Poland, Intelliseq operates in the Genetics & Genomics sector as a provider of a software-as-a-service (SaaS) platform. The company's iFlow platform addresses the bottleneck of genomic data interpretation by offering automated, compliant, and scalable analysis workflows tailored for clinical and research applications. Intelliseq's business model is centered on its platform, serving researchers and clinicians who need to derive actionable insights from next-generation sequencing (NGS) data efficiently. It appears to be a privately held, revenue-generating company with a commercial-stage software platform.

OncologyRare DiseasesPharmacogenetics

Technology Platform

iFlow: A cloud-based platform for automated, scalable, and compliant analysis and interpretation of next-generation sequencing (NGS) data. It features the GeneSpect suite of customizable workflow modules for specific clinical and research applications.

Opportunities

The rapid adoption of NGS in clinical diagnostics and the need for automated, compliant interpretation tools creates a large and growing market.
Expansion into the US market via its California entity and the increasing focus on preventive health through polygenic risk scores present significant growth avenues.

Risk Factors

Faces intense competition from both large, established genomics firms and agile startups.
Evolving regulatory landscapes for clinical software in the US and EU could impose additional compliance costs and complexities.
Success hinges on convincing traditional labs to adopt a new cloud-based platform.

Competitive Landscape

Operates in a crowded bioinformatics market competing with large sequencing companies (e.g., Illumina with DRAGEN), specialized software firms (e.g., Sophia Genetics, Fabric Genomics), and diagnostic giants. Differentiation is based on a strong compliance framework (ISO13485, HIPAA, GDPR), scalability, and a suite of ready-to-use clinical analysis modules.

More companies in Diagnostics & Precision Medicine →More companies in Poland →